title: Do low-dose anti-TNF regimens have a role in patients with ankylosing spondylitis?
authors.affiliation: Department of Rheumatology, Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich and.
authors.forename: Max
authors.initials: M
authors.lastname: Yates
authors.affiliation: Department of Rheumatology, Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich and.
authors.forename: Andrew
authors.initials: A
authors.lastname: Keat
authors.affiliation: Department of Rheumatology, Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich and karl.gaffney@nnuh.nhs.uk.
authors.forename: Karl
authors.initials: K
authors.lastname: Gaffney
mesh_terms: D018501:Antirheumatic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D001688:Biological Products / Q000008:administration & dosage* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D018501:Antirheumatic Agents; D001688:Biological Products; D014409:Tumor Necrosis Factor-alpha